UMB

Swiss Public Cloud Market Grows as Hyperscalers Expand

Retrieved on: 
Thursday, January 19, 2023
Mobile, Wireless, Technology, Security, Consulting, Professional Services, Software, Networks, Data Analytics, Data Management, IOT (Internet of Things), Cloud, SES Platform Services, UMB, Platform as a service, COVID-19, Swisscom, Atos, Rising Star, Texas, Consultant, Organization, Hyperscale computing, Research, ISG, IBM, Microsoft, Infrastructure as a service, AWS, Wipro, Research report, Software as a service, Accenture, SAP, DXC Technology, Network equipment

The 2022 ISG Provider Lens™ Public Cloud — Solutions and Services report for Switzerland finds that all but 5 percent of companies in Switzerland have used some cloud services.

Key Points: 
  • The 2022 ISG Provider Lens™ Public Cloud — Solutions and Services report for Switzerland finds that all but 5 percent of companies in Switzerland have used some cloud services.
  • Unregulated industries are the leading adopters of hyperscaler public cloud infrastructure, ISG says.
  • The report also examines other trends in the Swiss public cloud market, including a growing willingness to move SAP workloads to the cloud and the effect of sustainability goals on companies’ public cloud choices.
  • The 2022 ISG Provider Lens™ Public Cloud — Solutions and Services report for Switzerland evaluates the capabilities of 65 providers across six quadrants: Consulting and Transformation Services for Large Accounts, Consulting and Transformation Services for Midmarket, Managed Public Cloud Services for Large Accounts, Managed Public Cloud Services for Midmarket, Hyperscale Infrastructure and Platform Services, and SAP HANA Infrastructure Services.

Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis

Retrieved on: 
Friday, December 30, 2022
Peptide, Dexamethasone, UMB, Arthritis, Rheumatoid arthritis, Skin, SC, Patient, RA, University, Therapy, History of the University of Maryland, College Park, DEX, SILO, Fine chemical

ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced positive interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents. Silo Pharma is pursuing a development plan utilizing its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis (RA). 

Key Points: 
  • ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced positive interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents.
  • Silo Pharma is pursuing a development plan utilizing its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis (RA).
  • The drug used in the study was dexamethasone (DEX), a corticosteroid used for its anti-inflammatory and immunosuppressant effects.
  • “We believe that the positive results of these latest tests show that our peptide with DEX given subcutaneously was effective in controlling arthritis progression.

UMB Announces Conference Call to Discuss Fourth Quarter and Full-Year 2022 Results

Retrieved on: 
Wednesday, January 4, 2023
Finance, Consulting, Banking, Accounting, Professional Services, UMB Financial Corporation, Interest, UMB, UMBF, Financial adviser, Online shopping, Bank, Finance, Consulting, Banking, Accounting, Professional Services

UMB Financial Corporation (Nasdaq: UMBF), a financial services company, will release earnings results for the fourth quarter 2022 after market hours on Tuesday, January 24, 2023.

Key Points: 
  • UMB Financial Corporation (Nasdaq: UMBF), a financial services company, will release earnings results for the fourth quarter 2022 after market hours on Tuesday, January 24, 2023.
  • The company plans to host an investor conference call to discuss these results on Wednesday, January 25, 2023, at 8:30 a.m. (CT).
  • Interested parties may access the call by dialing (toll-free) 844-200-6205 or (international) 646-904-5544 and requesting to join the UMB Financial call with access code 216125.
  • The live call may also be accessed by visiting investorrelations.umb.com or by using the following the link:

Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue

Retrieved on: 
Monday, November 21, 2022
Degenerative disease, Peptide, RA, SILO, University, UMB, Patient, Nanoparticle, Joint, Toxicity, Rheumatoid arthritis, Inflammation, Central nervous system, History of the University of Maryland, College Park, CNS, Multiple sclerosis, Research, Therapy, Tendon, Psilocybin, PTSD, Epithelium, Fine chemical, Pharmaceutical industry

ENGLEWOOD CLIFFS, NJ, Nov. 21, 2022 (GLOBE NEWSWIRE) --  Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis (RA), designated as SPU-21, in human synovial tissue surrounding joints and tendons. The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue. Initial data from the study is expected during the first quarter of 2023.

Key Points: 
  • The three-month study will assess the binding affinity of the peptide in healthy human and RA synovial tissue.
  • SPU-21 was shown to inhibit arthritic progression in a preclinical animal model, so we are proceeding to advance our research into human synovial tissue, where we will first assess binding affinity, said Eric Weisblum, Chief Executive Officer of Silo Pharma.
  • Positive data from this important study could support further research into the interaction of our joint homing peptide as a potential therapy for autoimmune disorders such as rheumatoid arthritis and inflammation.
  • Under a commercial evaluation license and option agreement with the University of Maryland,Baltimore(UMB), Silo Pharma is advancing the development of UMBs liposomal homing peptide to deliver targeted therapeutics that could include psilocybin.

Alex. Brown Realty Announces John Prugh’s Retirement

Retrieved on: 
Thursday, November 17, 2022
Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Finance, Construction & Property, Asset Management, Banking, Baltimore School, Carey Business School, ABR, Johns Hopkins University, Alex, Trustee, The arts, NPR, Alex. Brown & Sons, The Advisory Board Company, Senior advisor, WYPR, Retirement, University, Advisory board, UMB, Financial adviser

Brown Realty has announced the retirement of John M. Prugh.

Key Points: 
  • Brown Realty has announced the retirement of John M. Prugh.
  • Mr. Prugh was responsible for expanding the firms client base from individual investors to include endowments, foundations, pension plans and other institutional investors.
  • In addition to his role at ABR, Mr. Prugh has held many leadership positions within the Baltimore community.
  • Brown Realty is an independent real estate investment manager specializing in value-add, opportunistic, and core-plus investments in the middle market.

UMB Opens Delaware Corporate Trust Office, Adds Delaware Statutory Trust Services

Retrieved on: 
Tuesday, November 15, 2022
Banking, Personal Finance, Professional Services, Finance, SVP, Blog, Delaware statutory trust, Senior, UMB Financial Corporation, COVID-19, ABS, UMBF, Head, UMB, Bank

UMB announced today it has obtained regulatory approval to offer Delaware Statutory Trust services through its subsidiary UMB Delaware Inc. Delaware Statutory Trust services will be provided through a recently opened office in Wilmington, Delaware led by industry veteran Kristin Moore, SVP, President of UMB Delaware Inc., Team Manager.

Key Points: 
  • UMB announced today it has obtained regulatory approval to offer Delaware Statutory Trust services through its subsidiary UMB Delaware Inc. Delaware Statutory Trust services will be provided through a recently opened office in Wilmington, Delaware led by industry veteran Kristin Moore, SVP, President of UMB Delaware Inc., Team Manager.
  • The Wilmington office is an important step for our fast-growing corporate trust group, said Mark Flannagan, Executive Vice President at UMB, Offering Delaware Statutory Trust services rounds out our full-service offering and further streamlines the client experience across a wide range of deals.
  • We are also pleased to welcome Kristin, who is among the most experienced corporate trust professionals in the region.
  • For more information, visit UMB.com , UMB Blog , UMB Facebook and UMB LinkedIn , or follow us on Twitter at @UMBBank.

Hamilton Lane Partners with Figure to Launch First Private Markets-Focused, Blockchain-Native Registered Investment Fund

Retrieved on: 
Wednesday, October 26, 2022
SAN, LinkedIn, U.S. Securities and Exchange Commission, Figure Technologies, Time, Fund, Communication, Sale, Efficiency, DFS, Lists of political entities by century, LLC, NASDAQ, HASH, Security (finance), SoFi, Investment, KYC/AML, Technology, Investment Company Act of 1940, Mission Asset Fund, Science and technology in Asia, Industry, UMB, PAF, Blockchain, CEO, Friction, Ecosystem, Asset, Prospectus, Adviser, Leadership, Cryptocurrency, Financial services, Figure

SAN FRANCISCO and CONSHOHOCKEN, Pa., Oct. 26, 2022 /PRNewswire/ -- Figure Technologies, Inc. ("Figure") and Hamilton Lane (NASDAQ: HLNE) are preparing to launch three new share classes of Hamilton Lane's private markets-focused fund registered under the Investment Company Act of 1940 ("1940 Act") that digitize the fund share ownership record on the Provenance Blockchain using Figure's Digital Fund Services ("DFS") platform.

Key Points: 
  • SAN FRANCISCO and CONSHOHOCKEN, Pa., Oct. 26, 2022 /PRNewswire/ -- Figure Technologies, Inc. ("Figure") and Hamilton Lane (NASDAQ: HLNE) are preparing to launch three new share classes of Hamilton Lane's private markets-focused fund registered under the Investment Company Act of 1940 ("1940 Act") that digitize the fund share ownership record on the Provenance Blockchain using Figure's Digital Fund Services ("DFS") platform.
  • Hamilton Lane, one of the largest private markets investment firms globally, first filed for the new share classes on October 26, 2022, for its Private Assets Fund ("PAF" or the "Fund").
  • Hamilton Lane is initially using DFS to streamline the primary issuance process and plans to launch two additional closed-end private market funds on the DFS platform in the coming months.
  • Hamilton Lane (NASDAQ: HLNE) is a leading private markets investment management firm providing innovative solutions to institutional and private wealth investors around the world.

Baker Hughes Names Nancy Buese as Chief Financial Officer

Retrieved on: 
Wednesday, October 19, 2022
CFO, MarkWest Energy, Transport, EVP, ESG, Newmont Corporation, NASDAQ, Hydrocarbon, Arthur Andersen, UMB Financial Corporation, Ernst, Acquisition, Simonelli, UMB, Board, CEO, Ernst & Young, GLOBE, GE Oil and Gas, COVID-19, Solution, Marathon Petroleum, Leadership, Management

HOUSTON and LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Baker Hughes(NASDAQ: BKR) has announced Nancy Buese as Chief Financial Officer (CFO) effective November 2, 2022.

Key Points: 
  • HOUSTON and LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Baker Hughes(NASDAQ: BKR) has announced Nancy Buese as Chief Financial Officer (CFO) effective November 2, 2022.
  • Nancy is a proven CFO and business leader, delivering impressive results throughout her career in the energy and mining sectors.
  • She brings diversified and valued experience leading finance teams for public companies, and I am excited to welcome her to Baker Hughes, said Lorenzo Simonelli, chairman & CEO of Baker Hughes.
  • Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide.

Paymode-X Surpasses 500k Vendors on Network

Retrieved on: 
Wednesday, October 19, 2022
Council of Science and Technology Advisors, General manager, Growth, Thoma Bravo, History, Net income, UMB, Financial management, GLOBE, United Kingdom, Online shopping, Cryptocurrency

Businesses now can pay 500,000+ vendors digitally within Paymode-X, and over 1.3 million suppliers with its extended supplier network.

Key Points: 
  • Businesses now can pay 500,000+ vendors digitally within Paymode-X, and over 1.3 million suppliers with its extended supplier network.
  • The network has also been named a Market Leader in the Ardent Partners 2021 ePaybables Technology Advisor report.
  • Jeff Feuerstein, SVP Product Management for Paymode-X at Bottomline adds We take a holistic view of our network.
  • Whether youre a buyer, a supplier, or both, our focus is on delivering value for all businesses on the network.

UMB Announces Conference Call to Discuss Third Quarter 2022 Results

Retrieved on: 
Wednesday, October 5, 2022
Professional Services, Technology, Software, Finance, Networks, Fintech, Internet, Interest, UMB Financial Corporation, Twitter, Nasdaq, Blog, UMB, UMBF

UMB Financial Corporation (Nasdaq: UMBF), a financial services company, will release earnings results for the third quarter 2022 after market hours on Tuesday, October 25, 2022.

Key Points: 
  • UMB Financial Corporation (Nasdaq: UMBF), a financial services company, will release earnings results for the third quarter 2022 after market hours on Tuesday, October 25, 2022.
  • The company plans to host an investor conference call to discuss these results on Wednesday, October 26, 2022, at 8:30 a.m. (CT).
  • Interested parties may access the call by dialing (toll-free) 844-200-6205 or (international) 646-904-5544 and requesting to join the UMB Financial call with access code 644175.
  • For more information, visit UMB.com , UMB Blog , UMB Facebook and UMB LinkedIn , or follow us on Twitter at @UMBBank.